Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Compound Edaravone Injection

DRUG

Edaravone Injection

Trial Locations (48)

100029

China-Japan Friendship Hospital, Beijing

100048

Navy General Hospital of The Chinese PLA, Beijing

100050

Beijing Tian Tan Hospital, Capital Medical University, Beijing

110016

The General Hospital of Shenyang Military, Chinese PLA, Shenyang

130011

The Forth Hospital of Jilin University, Siping

130041

The Second Hospital of Jilin University, Changchun

136000

Siping Central Hospital, Siping

150001

The Second Affiliated Hospital of Haerbin Medical University, Haerbin

200003

Shanghai Changzheng Hospital, Shanghai

200090

Yangpu Hospital, Tongji University, Shanghai

210006

Nanjing First Hospital, Nanjing

210009

Zhongda Hospital,Southeast University, Nanjing

210011

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

210029

Nanjing Brain Hospital, Nanjing

221006

The Affiliated Hospital of Xuzhou Medical College, Xuzhou

222002

Lianyungang First People's Hospital, Lianyungang

223300

Huai'an First Affiliated Hospital of Nanjing Medical University, Huai'an

225001

Northern Jiangsu People's Hospital, Yangzhou

Yangzhou No.1 People's Hospital, Yangzhou

250033

The Sceond Hospital of Shandong University, Jinan

252000

Liaocheng People's Hospital, Liaocheng

266011

Qingdao Municipal Hospital, Qingdao

300000

Tianjin People's Hospital, Tianjin

300052

Tianjin Medical University General Hospital, Tianjin

300060

Tianjin Huanhu Hospital, Tianjin

300211

The Second Hospital of Tianjin Medical University, Tianjin

323000

Lishui People's Hospital, Lishui

325000

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

350005

The First Affiliated Hospital of Fujian Medical University, Fuzhou

410005

Hunan Provincial People's Hospital, Changsha

421001

The First Affiliated Hospital of University of South China, Hengyang

450052

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

510515

Nanfang Hospital of Southern Medical University, Guangzhou

510630

The First Affiliated Hospital of Jinan University, Guangzhou

518020

Shenzhen People's Hospital, Shenzhen

518036

Peking University Shenzhen Hospital, Shenzhen

530031

Nanning Second People's Hospital, Nanning

541001

Affiliated Hospital of Guilin Medical University, Guilin

545005

Liuzhou Worker's Hospital, Liuzhou

550004

The Affiliated Hospital of Guizhou Medical University, Guiyang

610041

West China Hospital, Sichuan University, Chengdu

061000

Cangzhou Central Hospital, Cangzhou

014010

The First Affiliated Hospital of Baotou Medical College, Baotou

The Third Affiliated Hospital of Inner Mongolia Medical University, Baotou

014040

Central Hospital of Baotou, Baotou

010017

Inner Mongolia Autonomous Region People's Hospital, Hohhot

010050

Affiliated Hospital of Inner Mongolia Medical University, Hohhot

030001

The Second Affiliated Hospital of Shanxi Medical University, Taiyuan

All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY

NCT02430350 - Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter